0001209191-19-032465.txt : 20190523
0001209191-19-032465.hdr.sgml : 20190523
20190523183429
ACCESSION NUMBER: 0001209191-19-032465
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190521
FILED AS OF DATE: 20190523
DATE AS OF CHANGE: 20190523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AGUIAR ERIC
CENTRAL INDEX KEY: 0001262325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 19851556
MAIL ADDRESS:
STREET 1: 888 7TH AVENUE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-21
0
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001262325
AGUIAR ERIC
C/O AISLING CAPITAL LLC
888 SEVENTH AVENUE, 12TH FLOOR
NEW YORK
NY
10106
1
0
0
0
Stock Option (Right to Buy)
61.76
2019-05-21
4
A
0
18000
0.00
A
2029-05-20
Common Shares
18000
18000
D
The shares subject to this stock option will vest in full on the earlier of (a) May 21, 2020 or (b) the date of the 2020 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date.
/s/ Darren K. DeStefano, Attorney-in-fact
2019-05-23